ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LGVN vs BGMS // DIVIDEND YIELD & FCF PAYOUT SAFETY

Longeveron Inc. (Class A) (NASDAQ) VS. Bio Green Med Solution Inc. (NASDAQ) • 15-METRIC TALLY: LGVN 2 — BGMS 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LGVN VS. BGMS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LGVN BGMS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 67.00% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -49.90% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 LGVN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.0 43.2 -9.20 BGMS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $5.6M $5.5M $82.4K LGVN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LGVN REV BGMS REV LGVN GROSS % BGMS GROSS % LGVN FCF BGMS FCF
FY 2025 $1.2M $0 67.0% — -$18.9M -$4.8M
FY 2024 $2.4M $43.0K 78.8% — -$14.5M -$8.0M
FY 2023 $709.0K $0 — — -$19.0M -$16.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LGVN // BETA —
BGMS // BETA —